EP3749662 - THERAPEUTIC COMPOUNDS AND COMPOSITIONS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 02.12.2022 Database last updated on 19.07.2024 | |
Former | Request for examination was made Status updated on 13.11.2020 | ||
Former | The international publication has been made Status updated on 17.08.2019 | Most recent event Tooltip | 17.04.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Exithera Pharmaceuticals Inc. 1900 West Park Drive Suite 280 Westborough, MA 01581 / US | [2020/51] | Inventor(s) | 01 /
CHENARD, Bertrand, L. 7 Whaling Drive Waterford, CT 06385 / US | 02 /
XU, Yuelian 48 Highland Avenue East Haven, CT 06513 / US | 03 /
STASSEN, Frans, L. 6 Canal Park Suite 410 Cambridge, MA 02141 / US | 04 /
HAYWARD, Neil, J. 1900 West Park Drive Westborough, MA 01581 / US | 05 /
TENG, Zhiyao 705 North Mountain Road, Suite C115 Newington, CT 06111 / US | [2020/51] | Representative(s) | Harris, Jennifer Lucy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2020/51] | Application number, filing date | 19751349.2 | 04.02.2019 | [2020/51] | WO2019US16503 | Priority number, date | US201862627435P | 07.02.2018 Original published format: US 201862627435 P | [2020/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019156929 | Date: | 15.08.2019 | Language: | EN | [2019/33] | Type: | A1 Application with search report | No.: | EP3749662 | Date: | 16.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application. | [2020/51] | Search report(s) | International search report - published on: | US | 15.08.2019 | (Supplementary) European search report - dispatched on: | EP | 11.06.2021 | Classification | IPC: | C07D401/06, C07D405/14, C07D417/06, A61P9/10, A61P9/12, A61P11/00, A61P13/12, C07D401/14, C07D409/14, C07D413/14, C07D417/14, A61P29/00 | [2021/28] | CPC: |
C07D401/14 (EP,KR,US);
A61K31/4439 (KR);
A61P11/00 (EP,KR);
A61P13/12 (EP,KR);
A61P25/00 (KR);
A61P29/00 (EP);
A61P7/02 (KR);
A61P7/10 (KR);
A61P9/10 (EP,KR);
A61P9/12 (EP,KR);
C07D405/14 (EP,KR,US);
C07D409/14 (EP,KR,US);
|
Former IPC [2020/51] | C07D401/06, C07D405/14, C07D417/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/51] | Title | German: | THERAPEUTISCHE VERBINDUNGEN UND ZUSAMMENSETZUNGEN | [2020/51] | English: | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | [2020/51] | French: | COMPOSÉS ET COMPOSITIONS THÉRAPEUTIQUES | [2020/51] | Entry into regional phase | 14.08.2020 | National basic fee paid | 14.08.2020 | Search fee paid | 14.08.2020 | Designation fee(s) paid | 14.08.2020 | Examination fee paid | Examination procedure | 14.08.2020 | Examination requested [2020/51] | 05.01.2022 | Amendment by applicant (claims and/or description) | 02.12.2022 | Despatch of a communication from the examining division (Time limit: M06) | 04.07.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 07.09.2023 | Reply to a communication from the examining division | 28.03.2024 | Despatch of a communication from the examining division (Time limit: M06) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 07.09.2023 | Request for further processing filed | 07.09.2023 | Full payment received (date of receipt of payment) Request granted | 15.09.2023 | Decision despatched | Fees paid | Renewal fee | 25.02.2021 | Renewal fee patent year 03 | 25.02.2022 | Renewal fee patent year 04 | 27.02.2023 | Renewal fee patent year 05 | 27.02.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2006108039 (DAIAMED INC [US], et al); | [I]US2015225389 (CHRUSCIEL ROBERT A [US], et al); | [IP]WO2018118705 (EXITHERA PHARMACEUTICALS INC [US]) | International search | [X]US2015225389 (CHRUSCIEL ROBERT A [US], et al); | [PX]WO2018118705 (EXITHERA PHARMACEUTICALS INC [US]) |